BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24131357)

  • 1. Bilateral hypopyon uveitis secondary to mycosis fungoides with Sezary syndrome.
    LaMattina KC; Becker NM
    Ocul Immunol Inflamm; 2014 Jun; 22(3):246-7. PubMed ID: 24131357
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
    Curry JL; Prieto VG; Jones DM; Vega F; Duvic M; Diwan AH
    J Cutan Pathol; 2011 Mar; 38(3):295-7. PubMed ID: 19889052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Journal Club: Mycosis fungoides and Sézary syndrome: an update on a classic disease.
    González DV; Rosell-Díaz ÁM; Chircop I; Lé AM; Dege T; Byrne N; Reynaud V; García-Piqueras P
    Eur J Dermatol; 2023 Dec; 33(6):714-718. PubMed ID: 38465567
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH; Bishop K; Varghese A; Hoppe RT
    Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous T-cell lymphoma and atopy: is there an association?
    Mehrany K; El-Azhary RA; Bouwhuis SA; Pittelkow MR
    Br J Dermatol; 2003 Nov; 149(5):1013-7. PubMed ID: 14632807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wound assessment and evaluation.
    Hill MJ
    Dermatol Nurs; 2001 Jun; 13(3):223-4. PubMed ID: 11917457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular mucinosis: a critical reappraisal of clinicopathologic features and association with mycosis fungoides and Sézary syndrome.
    Cerroni L; Fink-Puches R; Bäck B; Kerl H
    Arch Dermatol; 2002 Feb; 138(2):182-9. PubMed ID: 11843637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is smoking associated with mycosis fungoides and Sézary syndrome?
    Chang HC; Tsai TY
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e381-e384. PubMed ID: 35023221
    [No Abstract]   [Full Text] [Related]  

  • 10. Palmoplantar hyperkeratosis in mycosis fungoides.
    Aram H; Zeidenbaum M
    J Am Acad Dermatol; 1985 Nov; 13(5 Pt 2):897-9. PubMed ID: 2933430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy associated with cutaneous T cell lymphoma.
    Bajel A; Yin Lin M; Hill PA; Goodman D; McCormack C; Foley P; Davison J; Hönemann D; Kenealy M; Lade S; Ryan G; Prince HM
    Leuk Lymphoma; 2009 Dec; 50(12):2083-5. PubMed ID: 19863174
    [No Abstract]   [Full Text] [Related]  

  • 12. Infections complicating mycosis fungoides and Sézary syndrome.
    Axelrod PI; Lorber B; Vonderheid EC
    JAMA; 1992 Mar; 267(10):1354-8. PubMed ID: 1740857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.
    Cook BE; Bartley GB; Pittelkow MR
    Ophthalmology; 1999 Jul; 106(7):1339-44. PubMed ID: 10406618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycosis fungoides and monoclonal dysglobulinemia].
    Gianadda B; Robart S; Brutzkus A; Perrot H
    Ann Dermatol Venereol; 1980; 107(1-2):71-4. PubMed ID: 6768335
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sézary syndrome with ascitis: case report and review of the literature].
    Nubourgh I; Van den Broeck K; Bradstreet C; Praet JP; Cantinieaux B
    Rev Med Brux; 2005; 26(5):445-50. PubMed ID: 16318098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study.
    Blaizot R; Ouattara E; Fauconneau A; Beylot-Barry M; Pham-Ledard A
    Br J Dermatol; 2018 Dec; 179(6):1322-1328. PubMed ID: 30098016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study.
    Bazarbachi A; Soriano V; Pawson R; Vallejo A; Moudgil T; Matutes E; Peries J; Molina A; de The H; Schulz TF; Catovsky D; Gill PS
    Br J Haematol; 1997 Sep; 98(4):927-33. PubMed ID: 9326191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
    Reddy R; Kim SJ
    Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.